Searching the Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Dipeptidyl peptidase (DPP)-4 is a multifunctional glycoprotein involved in various biological and pathologic processes. DPP-4 has been widely recognized as a therapeutic target for type 2 diabetes mellitus but is also implicated in the development of human malignancies. Here, we show that inhibition of DPP-4 accelerates breast cancer metastasis via induction of CXCL12/CXCR4, which activates mTOR to promote epithelial-mesenchymal transition (EMT). In cultured cells, DPP-4 knockdown induced EMT and cell migration. Treatment with the DPP-4 inhibitor KR62436 (KR) promoted primary tumor growth and lung metastasis in a 4T1 tumor allograft mouse model; DPP-4 knockdown in 4T1 cells displayed similar phenotypes in vivo and in vitro. KR treatment enhanced the levels of CXCL12/CXCR4 and phosphorylated mTOR, which were associated with the induction of EMT in metastatic cancer cells. KR-induced EMT in cancer cells was inhibited by treatment with the CXCR4 inhibitor AMD3100 or the mTOR inhibitor rapamycin, and AMD3100 suppressed KR-induced metastasis in vivo. Our findings suggest that DPP-4 plays a significant role in cancer biology and that inhibition of DPP-4 promotes cancer metastasis via induction of the CXCL12/CXCR4/mTOR/EMT axis. SIGNIFICANCE: These findings reveal that inhibition of DPP-4 increases the metastatic potential of breast cancer. This is especially important given the potential use of DPP-4 inhibition as a therapeutic strategy for type 2 diabetes.
Pubmed ID: 30584072
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets mTOR
View all literature mentionsThis monoclonal targets E Cadherin antibody [DECMA-1]
View all literature mentionsThis polyclonal targets alpha smooth muscle Actin
View all literature mentionsThis polyclonal targets Smad3
View all literature mentionsThis monoclonal targets Vimentin
View all literature mentionsThis polyclonal targets CXCR4 - Hematopoietic Stem Cell Marker
View all literature mentionsThis polyclonal targets SDF1 beta antibody
View all literature mentionsThis polyclonal targets TGF beta Receptor II antibody
View all literature mentionsThis monoclonal targets β-Actin
View all literature mentionsThis unknown targets
View all literature mentionsThis polyclonal targets SMAD3 phospho S423/phospho S425
View all literature mentionsThis polyclonal targets DPP4/CD26 antibody produced in goat
View all literature mentionsThis unknown targets Rat IgG (H+L)
View all literature mentionsThis polyclonal targets TGF beta Receptor I antibody produced in rabbit
View all literature mentionsThis unknown targets Rabbit IgG, F'2 Fragment Specific
View all literature mentionsThis unknown targets mTOR, phospho (Ser2481)
View all literature mentionsThis monoclonal targets Human/Mouse CXCL12/SDF-1 MAb (Clone 79014)
View all literature mentionsThis monoclonal targets TGF-beta 1,-2,-3
View all literature mentionsCell line MDA-MB-231 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line 4T1 is a Cancer cell line with a species of origin Mus musculus (Mouse)
View all literature mentionsStatistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.
View all literature mentionsCell line MCF-7 is a Cancer cell line with a species of origin Homo sapiens (Human)
View all literature mentionsCell line MCF-10A is a Spontaneously immortalized cell line with a species of origin Homo sapiens
View all literature mentionslaboratory mouse with name BALB/cByJJcl from MGI.
View all literature mentions